Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 1, 2005
Issued Date -
N/A
app pub date -
Nov 15, 2002
filing date -
Sep 27, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to methods of treating, preventing, and/or managing abnormal increases in gastrointestinal motility, and intestinal conditions that cause the same. Such conditions include, but are not limited to, irritable bowel syndrome (IBS), infectious diseases of the small and large intestines, and symptoms of any of the foregoing. In particular, the present invention discloses methods of using enriched (R)-verapamil, as well as compositions and formulations containing the same.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully